Commentary
Commentary
Democrats Abandon US Patients to Rescue Drug-Pricing Reform
Just a few days ago, it appeared that Democrats had given up on including prescription drug pricing reforms in their massive spending bill. But not anymore. In an eleventh-hour turn of events, congressional Democrats this week resurrected their long-standing desire to levy government price controls on prescription drugs. If lawmakers successfully deploy their latest ...
Sally C. Pipes
November 4, 2021
Business & Economics
Federal Covid-19 Response Hurt Small Business, Threatens Future Of American Entrepreneurship
Small business owners and entrepreneurs have plenty of barriers to success without considering the costs from the COVID-19 pandemic. High and excessively complex tax laws, the anti-growth reconciliation bill, and regulatory burdens like the pending congressional “Right to Work” bill and California’s AB5 law that is going national through the PRO ...
Wayne Winegarden
November 3, 2021
Commentary
Biden’s new plan isn’t any better for your health
Last week, President Joe Biden unveiled a new social spending framework that omitted many of the healthcare provisions Democrats have been calling for. One provision that has survived is a massive and wasteful expansion of Obamacare . In March, Congress made federal tax credits available to those shopping for coverage on the exchanges with ...
Sally C. Pipes
November 1, 2021
California
A Rare California Victory for Cutting Government Regulations
While criticizing California’s blue state agenda from a limited-government perspective requires little effort, it can be a wearying exercise. So it’s particularly refreshing when the legislature passes, and the governor signs, a bill that eases up on the bureaucracy. Even when the new law doesn’t do much. Because it creates ...
Kerry Jackson
October 29, 2021
Commentary
Single-Payer Will Worsen Healthcare Workers’ Plight
Healthcare workers are exchanging scrubs and gloves for signs and megaphones. In what’s been called “Striketober,” frontline staff are walking out of hospitals, emergency rooms, and doctor’s offices to insist on better pay, benefits, and hours. Earlier this month, Kaiser Permanente workers in California voted to authorize a strike over ...
Sally C. Pipes
October 25, 2021
Commentary
Real school crime – don’t blame parents
The National School Board Association’s recent letter to Attorney General Merrick Garland warning about “threats of violence and acts of intimidation” by parents distracts from the much larger problem of violence and crime in schools. In its letter, the NSBA does not cite any data to support its push to ...
Lance Izumi
October 22, 2021
Business & Economics
To Flip the Switch on Global Warming, Embrace Competitive Energy Markets
If Willie Phillips, President Biden’s nominee to serve on the Federal Energy Regulatory Commission (FERC) is confirmed by the U.S. Senate, Democrats will take a 3-2 majority on this important body that oversees the delivery of reliable and affordable power for the American people. If the Biden administration really wants ...
Wayne Winegarden
October 21, 2021
Commentary
Sally Pipes: Democrats’ Drug Pricing Reforms Aren’t What They Seem
As part of their spending bill, Congressional Democrats are advancing legislation that’ll empower Medicare to “negotiate” drug prices in the program’s Part B and Part D benefits. They insist this policy enjoys broad support among voters. But they’re misleading the public. What Democrats are proposing is in fact a sweeping ...
Sally C. Pipes
October 19, 2021
Commentary
Democrats Have Built a Healthcare Agenda Around an Imaginary Crisis
Is America in the midst of a health insurance crisis? That’s the picture Democrats in Washington are painting. According to their narrative, health coverage is out of reach for a number of Americans. Only an aggressive — and exorbitantly expensive — effort to expand the number of people covered by taxpayer-funded insurance ...
Sally C. Pipes
October 15, 2021
Commentary
Mixed Messaging On Boosters Leaves Americans Dazed And Confused
The Food and Drug Administration recently revised its emergency use authorization for Pfizer-BioNTech’s COVID-19 vaccine by approving a booster shot for individuals 65 and older, immunocompromised adults, and people with a high risk of exposure to the virus at work. It’s an exciting development for the nearly 80% of vaccinated Americans who want a ...
Sally C. Pipes
October 11, 2021
Democrats Abandon US Patients to Rescue Drug-Pricing Reform
Just a few days ago, it appeared that Democrats had given up on including prescription drug pricing reforms in their massive spending bill. But not anymore. In an eleventh-hour turn of events, congressional Democrats this week resurrected their long-standing desire to levy government price controls on prescription drugs. If lawmakers successfully deploy their latest ...
Federal Covid-19 Response Hurt Small Business, Threatens Future Of American Entrepreneurship
Small business owners and entrepreneurs have plenty of barriers to success without considering the costs from the COVID-19 pandemic. High and excessively complex tax laws, the anti-growth reconciliation bill, and regulatory burdens like the pending congressional “Right to Work” bill and California’s AB5 law that is going national through the PRO ...
Biden’s new plan isn’t any better for your health
Last week, President Joe Biden unveiled a new social spending framework that omitted many of the healthcare provisions Democrats have been calling for. One provision that has survived is a massive and wasteful expansion of Obamacare . In March, Congress made federal tax credits available to those shopping for coverage on the exchanges with ...
A Rare California Victory for Cutting Government Regulations
While criticizing California’s blue state agenda from a limited-government perspective requires little effort, it can be a wearying exercise. So it’s particularly refreshing when the legislature passes, and the governor signs, a bill that eases up on the bureaucracy. Even when the new law doesn’t do much. Because it creates ...
Single-Payer Will Worsen Healthcare Workers’ Plight
Healthcare workers are exchanging scrubs and gloves for signs and megaphones. In what’s been called “Striketober,” frontline staff are walking out of hospitals, emergency rooms, and doctor’s offices to insist on better pay, benefits, and hours. Earlier this month, Kaiser Permanente workers in California voted to authorize a strike over ...
Real school crime – don’t blame parents
The National School Board Association’s recent letter to Attorney General Merrick Garland warning about “threats of violence and acts of intimidation” by parents distracts from the much larger problem of violence and crime in schools. In its letter, the NSBA does not cite any data to support its push to ...
To Flip the Switch on Global Warming, Embrace Competitive Energy Markets
If Willie Phillips, President Biden’s nominee to serve on the Federal Energy Regulatory Commission (FERC) is confirmed by the U.S. Senate, Democrats will take a 3-2 majority on this important body that oversees the delivery of reliable and affordable power for the American people. If the Biden administration really wants ...
Sally Pipes: Democrats’ Drug Pricing Reforms Aren’t What They Seem
As part of their spending bill, Congressional Democrats are advancing legislation that’ll empower Medicare to “negotiate” drug prices in the program’s Part B and Part D benefits. They insist this policy enjoys broad support among voters. But they’re misleading the public. What Democrats are proposing is in fact a sweeping ...
Democrats Have Built a Healthcare Agenda Around an Imaginary Crisis
Is America in the midst of a health insurance crisis? That’s the picture Democrats in Washington are painting. According to their narrative, health coverage is out of reach for a number of Americans. Only an aggressive — and exorbitantly expensive — effort to expand the number of people covered by taxpayer-funded insurance ...
Mixed Messaging On Boosters Leaves Americans Dazed And Confused
The Food and Drug Administration recently revised its emergency use authorization for Pfizer-BioNTech’s COVID-19 vaccine by approving a booster shot for individuals 65 and older, immunocompromised adults, and people with a high risk of exposure to the virus at work. It’s an exciting development for the nearly 80% of vaccinated Americans who want a ...